Effect of MSD on FCR Among Gastric Cancer Survivors

The goal of this clinical trial is to explores the effect of marital self disclosure intervention on fear of cancer recurrence and dyadic coping ability in gastric cancer survivors and their spouses. The main questions are: What is the level of fear of cancer recurrence among gastric cancer survivors and their spouse? What is the level of dyadic coping ability among gastric cancer survivors and their spouse?What is the effect of marital self-disclosure intervention on fear of cancer recurrence and dyadic coping ability in the gastric cancer survivors and their spouses? Participants will accept the intervention of marital self disclosure for 4 times (4 cycles of chemotherapy) with different topics. Researchers will compare with control group to see if the level of fear of cancer recurrence and dyadic coping ability will be improved.

Inclusion Criteria:The disease meets the diagnostic criteria of "Guidelines for Diagnosis and Treatment of Gastric Cancer"(Department of Medical Affairs, 2019), the preoperative gastroscopy and pathological diagnosis are advanced gastric cancer, and the postoperative pathological classification is type II, III or IVAge ≥ 18 yearsAble to write and oral communicate effectively by themselfThe main caregiver is their spouseClear consciousness, no understanding barriersAgree to participate in this studyExclusion Criteria:History of receiving a structured psychological intervention from a psychiatrist or a psychologistCognitive disorders or psychiatric disorders (according to the DSM-V)Severe visual, hearing and speech impairmentWith previous or concurrent malignant tumorsWith severe complications, such as gastrointestinal obstruction, perforation, etc.